Berzingi Seher, Piechowski Kara, Hendricks Emily, Colantonio Mark, Anandarm Asuwin, Perkowski Gregory, Miller Tyler, Conte Justin, Nassar Sameh, Kaseer Belal, Liriano Marcelino Mederos, Avalon Juan Carlo, Chapman Kyle, Patel Brijesh
Department of Medicine, West Virginia University (WVU) School of Medicine, Morgantown, WV, USA.
West Virginia University (WVU) Medicine, Morgantown, WV, USA.
Am J Prev Cardiol. 2024 Aug 11;19:100719. doi: 10.1016/j.ajpc.2024.100719. eCollection 2024 Sep.
Mobile low-dose computed tomography (LDCT) lung screenings are part of an outreach program in rural Appalachia to detect early lung cancer. Coronary artery calcium (CAC) scoring on LDCT can identify calcium deposits in coronary arteries and can prompt consideration of risk modification for prevention of cardiovascular disease (CVD) events. It is not known if Lung CT Screening Reporting & Data System (Lung-RADS) scoring correlates with CAC scores. There is no clear guidance for patients undergoing LDCT screenings to receive follow-up regarding CAC or prevention of associated CVD risk.
This was a retrospective review of mobile LDCT LCS in adults with no known history of CVD. CT images were obtained at 100 kVp with a slice thickness of 3 mm. Agatston CAC scoring was performed retroactively. Lung-RADS scores were categorized as: Negative (1), Benign (2), Probably Benign (3), and Suspicious (4). CAC scoring was grouped as 0, 1-100, 101-399, and ≥400. Descriptive statistics and chi-square analyses were utilized.
A total of 526 LDCT screenings were included. Over 54 % of patients had coronary calcification on LDCT LCS. 161 patients (30.6 %) had a CAC score of ≥100 and 75 patients (14.3 %) had a CAC score ≥400. Of patients with a CAC score ≥100, 7.5 % received referrals for follow-up after the LDCT screen and 9.3 % had additional cardiac testing. Of those with a CAC score ≥100 not already on a statin (45.3 %) and not already on aspirin (63.3 %), few were started within 3 months of LDCT for prevention (8.2 % and 5.9 % respectively). Among patients with a Lung-RADS score of 4, 17 % had a CAC score >400, whereas only 12 % with a Lung-RADS score of 1 fell into the same CAC category. Higher Lung-RADS scores correlated with fewer patients with CAC of 0. A significant correlation was observed between higher Lung-RADS scores and elevated CAC scores ( = 0.02).
In patients with no CVD history, coronary artery calcification was frequently identified on mobile LDCT lung screenings in rural communities. Patients with higher probabilities of malignant lung nodules may also be at increased risk for significant coronary artery disease. Calcium scoring from LDCT screenings allowed for simultaneous assessment of lung cancer and CVD risk. Unfortunately, few referrals or CVD prevention medications were initiated. Awareness of CAC score utility, follow-up for identified coronary calcifications, and consideration of primary prevention medications when indicated, would be beneficial in patients undergoing LDCT lung screenings, especially in rural areas with limited healthcare access.
移动低剂量计算机断层扫描(LDCT)肺部筛查是阿巴拉契亚农村地区一项外展项目的一部分,用于早期肺癌检测。LDCT上的冠状动脉钙化(CAC)评分可识别冠状动脉中的钙沉积,并可促使考虑进行风险调整以预防心血管疾病(CVD)事件。目前尚不清楚肺部CT筛查报告与数据系统(Lung-RADS)评分是否与CAC评分相关。对于接受LDCT筛查的患者,在CAC或相关CVD风险预防方面的后续跟进没有明确指导。
这是一项对无已知CVD病史的成年人进行移动LDCT肺癌筛查(LCS)的回顾性研究。CT图像在100 kVp下获取,层厚为3 mm。对Agatston CAC评分进行追溯性分析。Lung-RADS评分分为:阴性(1)、良性(2)、可能良性(3)和可疑(4)。CAC评分分为0、1 - 100、101 - 399和≥400。采用描述性统计和卡方分析。
共纳入526次LDCT筛查。超过54%的患者在LDCT LCS上有冠状动脉钙化。161例患者(30.6%)的CAC评分为≥100,75例患者(14.3%)的CAC评分为≥400。在CAC评分≥100的患者中,7.5%在LDCT筛查后接受了后续跟进转诊,9.3%进行了额外的心脏检查。在那些CAC评分≥100且未服用他汀类药物(45.3%)和未服用阿司匹林(63.3%)的患者中,很少有人在LDCT后3个月内开始进行预防用药(分别为8.2%和5.9%)。在Lung-RADS评分为4的患者中,17%的CAC评分>400,而Lung-RADS评分为1的患者中只有12%属于同一CAC类别。较高的Lung-RADS评分与CAC为0的患者较少相关。观察到较高的Lung-RADS评分与升高的CAC评分之间存在显著相关性(=0.02)。
在无CVD病史的患者中,农村社区的移动LDCT肺部筛查经常发现冠状动脉钙化。恶性肺结节可能性较高的患者也可能有患严重冠状动脉疾病的风险增加。LDCT筛查中的钙评分允许同时评估肺癌和CVD风险。不幸的是,很少有转诊或启动CVD预防药物。了解CAC评分的效用、对已识别的冠状动脉钙化进行后续跟进以及在有指征时考虑使用一级预防药物,对接受LDCT肺部筛查的患者有益,尤其是在医疗保健机会有限的农村地区。